Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cardiac xenotransplantation

Michael X Pham¹, Sharon A Hunt, Frances L Johnson

¹Division of Cardiovascular Medicine, Stanford University School of Medicine, California 94304-5406, USA. mpham@stanford.edu

Coronary Artery Disease

|March 17, 2004

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy.

European journal of nuclear medicine and molecular imaging·2023

Same author

Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors.

European journal of nuclear medicine and molecular imaging·2023

Same author

Pre-clinical Evaluation of Biomarkers for Early Detection of Nephrotoxicity Following Alpha-particle Radioligand Therapy.

bioRxiv : the preprint server for biology·2023

Same author

Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for <sup>203</sup>Pb and <sup>212</sup>Pb-Based Theranostics.

Pharmaceutics·2023

Same author

Are we ready for building transition programs for heart transplant recipients in Japan? - Knowing the unique background is the first step for discussion.

Frontiers in pediatrics·2022

Same author

Dosimetry of [<sup>212</sup>Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free <sup>208</sup>Tl on Tissue Absorbed Doses.

Molecules (Basel, Switzerland)·2022